Prevalence and factors associated with cervical cancer preventive screening in a Peruvian region

Estudios originales

Published on 25 de septiembre de 2023 | http://doi.org/10.5867/medwave.2023.08.2709

Prevalence and factors associated with cervical cancer preventive screening in a Peruvian region

Crude and adjusted indicators of association between knowledge of cervical cancer factors and performing screening tests.

Preventive screening			Crude model		Adjusted model¹
No	Yes	P value	RPc (95% CI)	P value	RPa (95% CI)	P value
Is it possible to prevent cancer?
60 (74.1)	21 (25.9)	< 0.001	Ref.		Ref.
507 (47.6)	558 (52.4)		2.02 (1.39 to 2.93)	< 0.001	1.47 (1.03 to 2.12)	0.034
Have you ever heard of cervical cancer?
64 (79.0)	17 (21.0)	< 0.001	Ref.		Ref.
503 (47.2)	562 (52.8)		2.51 (1.64 to 3.85)	< 0.001	2.18 (1.38 to 3.44)	0.001
Have you ever heard of HPV?
155 (81.2)	36 (18.8)	< 0.001	Ref.		Ref.
412 (43.1)	543 (56.9)		3.01 (2.23 to 4.07)	< 0.001	2.90 (2.15 to 3.91)	< 0.001
Do you think HPV can cause cervical cancer?
114 (57.6)	84 (42.4)	0.012	Ref.		Ref.
453 (47.8)	495 (52.2)		1.23 (1.03 to 1.46)	0.019	1.09 (0.94 to 1.28)	0.043

95% CI, 95% confidence interval.HPV, human papillomavirus. RPa, adjusted prevalence ratio. RPc, crude prevalence ratio. Ref., reference variable.

Notes: ¹Adjusted for all variables in the table.

Source: Own database from the study results.